New treatment options for hypertension during acute ischemic or hemorrhagic stroke.

New treatment options for hypertension during acute ischemic or hemorrhagic stroke. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

New treatment options for hypertension during acute ischemic or hemorrhagic stroke. Abstract Text:

J David Spence,

Widespread reluctance to treat hypertension during acute stroke is based on historical accounts of unfavorable outcomes of treatment that were badly done: therapies that cannot be controlled, such as sublingual nifedipine, oral or intramuscular antihypertensive drugs may drop blood pressure precipitously, leading to worsening of ischemia. Case fatality in stroke obeys a U-shaped relationship: blood pressures that are either too low or too high are associated with worse outcomes both in ischemic stroke and in intracerebral hemorrhage. Very high blood pressures should be lowered in acute stroke, and there are some circumstances in which high blood pressure must be treated despite the presence of stroke. To avoid worsening of ischemia by reduction in cerebral blood flow, it is necessary to treat high blood pressure in acute stroke with drugs that can be controlled; this usually means giving drugs by intravenous infusion; however, there is recent evidence that transdermal administration of nitrates, which can be removed if pressure is too low, is a convenient alternative that does not reduce cerebral blood flow in acute stroke.

New treatment options for hypertension during acute ischemic or hemorrhagic stroke. Publishing Authors By Initials

JD Spence,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

New treatment options for hypertension during acute ischemic or hemorrhagic stroke. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Current treatment options in cardiovascular medici

VOLUME: 9

Page Numbers: 242-6

Journal Abbreviation:

ISSN: 1092-8464

DAY: 2

MONTH: Jun

YEAR: 2007

New treatment options for hypertension during acute ischemic or hemorrhagic stroke. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9815942

New treatment options for hypertension during acute ischemic or hemorrhagic stroke. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: New treatment options for hypertension during acute ischemic or hemorrhagic stroke. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for New treatment options for hypertension during acute ischemic or hemorrhagic stroke.

AFFILIATION: J. David Spence, MD Stroke Prevention & Atherosclerosis Research Centre, Robarts Research Institute, 1400 Western Road, London, ON N6G 2V2, Canada. dspence@robarts.ca.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Curr Treat Options Cardiovasc

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

New treatment options for hypertension during acute ischemic or hemorrhagic stroke Related Publications

• A time of change in abortion.
• Addressing a vascular endothelium array with blood components using underlying microfluidic channels.
• Alcohol problems in Alaska Natives: lessons from the Inuit.
• An observational method of assessing handedness in children and adults.
• An outbreak of poliomyelitis.
• Audiovisual asynchrony modulates the Colavita visual dominance effect.
• Bioterrorism: prevention, preparation, or politics.
• Chemistry and atomic energy.
• Crossmodal change blindness between vision and touch.
• Dose, exposure time and resolution in serial X-ray crystallography.
• Effects of childhood hearing loss on organization of semantic memory: typicality and relatedness.
• Elevated heart rate as a predictor of PTSD six months following accidental pediatric injury.
• Evaluating the influence of the 'unity assumption' on the temporal perception of realistic audiovisual stimuli.
• Fluorescence monitoring of ATP-stimulated, endothelium-derived nitric oxide production in channels of a poly(dimethylsiloxane)-based microfluidic device.
• Gene conversion mutation in crystallin, beta-B2 (CRYBB2) in a Chilean family with autosomal dominant cataract.
• How 'special' is the human face? Evidence from an audiovisual temporal order judgment task.
• Metal-activated C-peptide facilitates glucose clearance and the release of a nitric oxide stimulus via the GLUT1 transporter.
• Multisensory cues capture spatial attention regardless of perceptual load.
• Multisensory in-car warning signals for collision avoidance.
• Nested case-control study of autoimmune disease in an asbestos-exposed population.
• New treatment options for hypertension during acute ischemic or hemorrhagic stroke.
• Olfactory cues modulate facial attractiveness.
• Perceptual load affects exogenous spatial orienting while working memory load does not.
• Perspective on the efficacy analysis of the Vitamin Intervention for Stroke Prevention trial.
• Red blood cell stimulation of platelet nitric oxide production indicated by quantitative monitoring of the communication between cells in the bloodstream.
• Seeing the light: exploring the Colavita visual dominance effect.
• Should emergency departments offer postexposure prophylaxis for non-occupational exposure to HIV?
• The correlation of carotid plaque pathohistological features and neurological symptoms: A meta-analysis of observational studies.
• The modulation of haptic line bisection by a visual illusion and optokinetic stimulation.
• Upper urinary tract anomalies.